Discovery of Vascular Endothelial Growth Factor Receptor 2 Inhibitors Employing Junction Tree Variational Autoencoder with Bayesian Optimization and Gradient Ascent.

ABSTRACT: In the development of anticancer medications, vascular endothelial growth factor receptor 2 (VEGFR-2), which belongs to the protein tyrosine kinase family, emerges as one of the most significant targets of interest. The ongoing Food and Drug Administration (FDA) approval of novel therapeutic medicines toward VEGFR-2 emphasizes the urgent need to discover sophisticated molecular structures that are capable of reliably limiting VEGFR-2 activity. Recognizing the huge potential of deep-learning-based molecular model advancements, we focused our study on exploring the chemical space to find small molecules potentially inhibiting VEGFR-2. To achieve this goal, we utilized the junction tree variational autoencoder in combination with two optimization approaches on the latent space: the local Baye

SUBMITTER: Truong GB 

PROVIDER: S-EPMC11603221 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature